1. Henderson IC: Principles in the management of metastatic disease. Chemotherapy for metastatic disease.In: Harris JR, Hellman S, Henderson IC, Kinne DW (eds) Breast Diseases. J.B. Lippincott Company, Philadelphia, 1991, pp 604?665
2. Greenspan EM, Fieber M, Lesnick G, Edelman S: Response of advanced breast carcinoma to the combination of the antimetabolite, methotrexate, and the alkylating agent, thiotepa. J Mt Sinai Hospital 30: 246?267, 1963
3. Cooper RG: Combination chemotherapy in hormone resistant breast cancer. Proc Am Assoc Cancer Res 10: 15, 1969
4. Yap HY, Blumenschein GR, Schell FC, Buzdar AU, Valdivieso M, Bodey GP: Dihydroxyanthracenedione: A promising new drug in the treatment of metastatic breast cancer. Ann Intern Med 95: 694?697, 1981
5. Bull J, Tormey D, Li SH, Carbone PP, Falkson G, Blom J, Perlin E, Simon R: A randomized comparative trial of Adriamycin versus methotrexate in combination drug therapy. Cancer 41: 1649?1657, 1978